Assembly Biosciences ASMB Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Efficiency | ||||||
| Asset turnover | 0.4×0.0× | 0.4×+0.2× | 0.2×-0.1× | 0.3×0.0× | 0.3×+0.1× | |
| Liquidity | ||||||
| Current ratio | 6.6×+1.4× | 5.2×+0.8× | 4.4×+2.8× | 1.6×-0.4× | 2×-0.4× | |
| Quick ratio | 6.6×+1.4× | 5.2×+0.8× | 4.4×+2.8× | 1.6×-0.4× | 2×-0.4× | |
| Cash ratio | 0.9×-0.3× | 1.2×+0.8× | 0.4×-0.1× | 0.5×0.0× | 0.5×-0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×-0.1× | 0.2×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $11.75-36.3% | $18.44+28.1% | $14.40+509% | $2.36-34.6% | $3.61-34.9% | |
| Valuation | ||||||
| Market capitalization | $480.77M+262% | $537.94M+174% | $196.41M+49.5% | $131.37M+83.1% | $71.73M-28.5% | |
| Enterprise value | $452.14M+302% | $482.12M+173% | $176.63M+60.2% | $110.24M+115% | $51.34M-21.1% | |
| Price / sales | 6.8×+2.6× | 7.4×+2.2× | 5.3×+1.3× | 4×+1.7× | 2.2×-1.3× | |
| Price / book | 2.4×-2.5× | 2.6×+1.5× | 1.1×-6.2× | 7.3×+4.6× | 2.6×-0.4× | |
| EV / sales | 6.4×+2.9× | 6.7×+1.9× | 4.7×+1.4× | 3.3×+1.7× | 1.6×-0.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Assembly Biosciences's ratios come from?
- Every ratio is computed from Assembly Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
